Use of icaritin for the preparation of a composition for cancer treatment

• 收藏
• 分享

专利权人:

北京盛諾基医薬科技有限公司

发明人:

孟坤,丁紅霞,李抒,托▲や▼,沈月秋

申请号：

JP2014114147

公开号：

JP6433686B2

申请日:

2014.06.02

申请国别(地区):

JP

年份:

2018

代理人:

摘要：

The present invention provides the use of Icaritin for the preparation of a composition for treating cancer, wherein the composition is orally administered to a patient at least one cycle, each cycle comprising a continuous 28-day dosing schedule, in which Icaritin is administered at least once daily, at a dosage of 400-1800 mg daily. The patients treated with Icaritin according to the present method receive better treatment, with reduced adverse effects.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/